This trial is testing how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer.
1 Primary · 8 Secondary · Reporting Duration: Up to 5 years
Active Control
Experimental Treatment
475 Total Participants · 2 Treatment Groups
Primary Treatment: Transurethral Resection of Bladder Tumor · No Placebo Group · Phase 3
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: